Recent Updates
Recently added Catalysts
BSX

Boston Scientific to Present an Overview of its Endoscopy Business Boston Scientific Corporation (NYSE: BSX) will hold a review of its Endoscopy business, including its Bronchial Thermoplasty opportunity, on Monday,...

Key Takeaway: NATICK, Mass. , June 6, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX ) will hold a review of its Endoscopy business, including its Bronchial Thermoplasty opportunity, on Monday, June 11, 2012 , from 1:30 p.m. EDT to approximately 4:00 p.m. EDT . Mike Mahoney , pr

Full Press Release Details

NATICK, Mass. , June 6, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX ) will hold a review of its Endoscopy business, including its Bronchial Thermoplasty opportunity, on Monday, June 11, 2012 , from 1:30 p.m. EDT to approximately 4:00 p.m. EDT . Mike Mahoney , president of Boston Scientific, will lead the meeting which will include presentations by David Pierce , president of the Endoscopy division. A question and answer session will follow the presentations that will include Messrs. Mahoney and Pierce, and other members of the Boston Scientific senior executive management team.
The company will host a live webcast of the meeting to provide access to interested parties. Webcast registration is available on the Investor Relations section of the Boston Scientific website at www.bostonscientific.com/investors . Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.
A replay of the webcast will be archived and available in the Investor Relations section of the company's website beginning approximately one hour following the completion of the meeting.
About Boston Scientific
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com .
Steven Campanini 508-652-5740 (office) Media Relations Boston Scientific Corporation [email protected]
Sean Wirtjes 508-652-5305 (office) Investor Relations Boston Scientific Corporation [email protected]
SOURCE Boston Scientific Corporation

21 %

Last updated: Jun 6, 2012